Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without st-segment elevation

Journal of the American College of Cardiology

Volumn 60, Issue 24, 2012, Pages 2490-2499

  Mehta, Shamir R ^a   Jolly, Sanjit S ^a   Cairns, John ^b   Niemela, Kari ^c   Rao, Sunil V ^d   Cheema, Asim N ^e   Steg, Philippe Gabriel ^f   Cantor, Warren J ^g   Džavík, Vladimír ^h   Budaj, Andrzej ⁱ   Rokoss, Michael ^a   Valentin, Vicent ^j   Gao, Peggy ^a   Yusuf, Salim ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^h UNIVERSITY HEALTH NETWORK   (Canada)

ⁱ GROCHOWSKI HOSPITAL   (Poland)

^j HOSPITAL UNIVERSITARIO DR PESET   (Spain)

more..

Author keywords

bleeding; percutaneous coronary intervention; radial artery; ST segment elevation myocardial infarction; vascular access

Indexed keywords

ADULT; ARTERY BYPASS; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEATH; FEMALE; FEMORAL ARTERY ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OUTCOME ASSESSMENT; PARALLEL DESIGN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RADIAL ARTERY ACCESS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR ACCESS;

ACUTE CORONARY SYNDROME; AGED; CATHETERIZATION, PERIPHERAL; FEMALE; FEMORAL ARTERY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RADIAL ARTERY; TREATMENT OUTCOME;

EID: 84871267678     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.07.050     Document Type: Article

References (28)

1. E.C. Keeley, J.A. Boura, C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
2. S.R. Mehta, C.P. Cannon, K.A. Fox Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials JAMA 293 2005 2908 2917
3. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
4. S.V. Rao, K. O'Grady, K.S. Pieper Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
5. M. Moscucci, K.A. Fox, C.P. Cannon Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
6. S. Yusuf, S.R. Mehta, S. Chrolavicius Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 354 2006 1464 1476
7. S.R. Mehta, W.E. Boden, J.W. Eikelboom Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials Circulation 118 2008 2038 2046
8. G.W. Stone, B. Witzenbichler, G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
9. S.V. Rao, F.S. Ou, T.Y. Wang Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry J Am Coll Cardiol Intv 1 2008 379 386
10. S. Deftereos, G. Giannopoulos, K. Raisakis Transradial access as first choice for primary percutaneous coronary interventions: experience from a tertiary hospital in Athens Hellenic J Cardiol 52 2011 111 117
11. J. Eichhofer, E. Horlick, J. Ivanov Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience Am Heart J 156 2008 864 870
12. M. Hamon, S. Mehta, P.G. Steg Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes EuroIntervention 7 2011 91 97
13. A.J. Chase, E.B. Fretz, W.P. Warburton Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) Heart 94 2008 1019 1025
14. S.S. Jolly, S. Amlani, M. Hamon, S. Yusuf, S.R. Mehta Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
15. A. Vorobcsuk, A. Konyi, D. Aradi Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction Systematic overview and meta-analysis Am Heart J 158 2009 814 821
16. M. Valgimigli, F. Saia, P. Guastaroba transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) Multicenter Registry J Am Coll Cardiol Intv 5 2012 23 35
17. S.S. Jolly, S. Yusuf, J. Cairns Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Lancet 377 2011 1409 1420
18. R. Mathews, E.D. Peterson, A.Y. Chen In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry(R)-GWTG Am J Cardiol 107 2011 1136 1143
19. S.R. Mehta, J.P. Bassand, S. Chrolavicius Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy Am Heart J 156 2008 1080 1088
20. S.S. Jolly, K. Niemela, D. Xavier Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes Am Heart J 161 2011 254 260
21. S. Savonitto, D. Ardissino, C.B. Granger Prognostic value of the admission electrocardiogram in acute coronary syndromes JAMA 281 1999 707 713
22. K.A. Fox, P.G. Steg, K.A. Eagle Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900
23. S. Yusuf, J. Wittes, J. Probstfield, H.A. Tyroler Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials JAMA 266 1991 93 98
24. S. Kaul, G.A. Diamond Trial and error How to avoid commonly encountered limitations of published clinical trials J Am Coll Cardiol 55 2010 415 427
25. D.J. Quinlan, J.W. Eikelboom, S.G. Goodman Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes Eur Heart J 32 2011 2256 2265
26. R. Mehran, S.V. Rao, D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
27. E. Romagnoli, G. Biondi-Zoccai, and A. Sciahbasi Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study J Am Coll Cardiol 2012 in press
28. P. Genereux, R. Mehran, T. Palmerini Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial EuroIntervention 7 2011 905 916